Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer

Psycho-oncology
K TillerL Andrews

Abstract

Little research is available on the level of knowledge about ovarian cancer risk management options in women at increased risk for this disease. The study objectives were to evaluate this together with the information and ovarian cancer risk management preferences of high-risk women. One hundred and twenty-nine women were assessed after their attendance at one of six familial cancer clinics in relation to knowledge of surveillance and/or preventative strategies for reduction of ovarian cancer risk, preferences for particular strategies, and information preferences. Screening was selected by 57 (44%) women as the preferred risk management option. One hundred and five women (82%) indicated a wish for as much information as possible about ovarian cancer, including both good and bad outcomes and 114 (89%) reported a preference for sharing treatment decisions with their health professional. Participants' knowledge about ovarian cancer risk management options was significantly associated with educational levels (Z = -3.2, p=0.001) and whether or not ovarian cancer was included in the family history (Z = -2.3, p = 0.018). Findings from this present study indicate that women at increased risk of ovarian cancer who attend familial cance...Continue Reading

References

Sep 1, 1992·Journal of Clinical Epidemiology·L F Degner, J A Sloan
Jun 1, 1980·Annals of Internal Medicine·B R CassilethV March
Apr 10, 1995·American Journal of Medical Genetics·M J SellerG S Tint
Apr 21, 1993·Journal of the National Cancer Institute·F J WardleS Campbell
Jan 15, 1997·Journal of the National Cancer Institute·C LermanM M Reed
Jul 1, 1997·Medical Decision Making : an International Journal of the Society for Medical Decision Making·R L Street, B Voigt
Jul 29, 1998·Social Science & Medicine·L Rochaix
Sep 10, 1998·Patient Education and Counseling·H W van den Borne
Sep 11, 1998·Patient Education and Counseling·P ButowM Tattersall
Nov 18, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F EisingerJ Feingold
Dec 16, 1998·British Journal of Obstetrics and Gynaecology·R BellT Sheldon
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L G BlumanE P Winer
Sep 2, 1999·Journal of the National Cancer Institute·T R RebbeckB L Weber
Dec 22, 1999·American Journal of Preventive Medicine·D L Frosch, R M Kaplan
Feb 9, 2000·Journal of Medical Genetics·G ElwynA Clarke
Mar 31, 2000·BMJ : British Medical Journal·G M LeydonK McPherson
Jun 1, 2000·Gynecologic Oncology·D E StewartB Rosen
Oct 12, 2000·JAMA : the Journal of the American Medical Association·D M GrabrickT A Sellers
Jul 28, 2001·The New England Journal of Medicine·B ModanUNKNOWN National Israel Ovarian Cancer Study Group
Oct 1, 1995·Psycho-oncology·Lesley FallowfieldShon Lewis
Jan 5, 2002·The New England Journal of Medicine·S A NarodUNKNOWN Hereditary Ovarian Cancer Clinical Study Group
May 25, 2002·The New England Journal of Medicine·Noah D KauffKenneth Offit
May 25, 2002·The New England Journal of Medicine·Timothy R RebbeckUNKNOWN Prevention and Observation of Surgical End Points Study Group
Oct 10, 2002·The Lancet Oncology·Michael Jefford, Martin H N Tattersall
Feb 15, 2003·Gynecologic Oncology·L ElitT Whelan

❮ Previous
Next ❯

Citations

Sep 25, 2010·Cancer Causes & Control : CCC·Sandra C JonesDonald C Iverson
Jul 4, 2006·Familial Cancer·Yoland C AntillKelly-Anne Phillips
Apr 3, 2008·American Journal of Public Health·Laura A SiminoffSaid Ibrahim
Oct 5, 2006·Transplant International : Official Journal of the European Society for Organ Transplantation·Anthony RenshawPeter E M Butler
Jun 27, 2013·Psycho-oncology·Kate J LiffordUNKNOWN PsyFOCS Management Group
Mar 5, 2015·Journal of Genetic Counseling·Louise HeinigerUNKNOWN kConFab Psychosocial Group on behalf of the kConFab Investigators
Dec 19, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Clara L GaffGeoffrey Lindeman
Feb 7, 2007·Current Opinion in Psychiatry·Prabha S Chandra, Sanjeev Ranjan
Apr 11, 2021·Hereditary Cancer in Clinical Practice·Bettina MeiserUNKNOWN ICCon Audit Study Collaborative Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Epidemiology
Tarani ChandolaDavid Blane
The Journal of the American Academy of Psychiatry and the Law
Heidi S VermettePaul S Appelbaum
Medical Decision Making : an International Journal of the Society for Medical Decision Making
H A Llewellyn-ThomasE C Thiel
© 2021 Meta ULC. All rights reserved